Accelerated Immuno Chemoradiotherapy Based on FDG-PET/CT for Small Volume in Locally Advanced NSCLC (PACCELIO) – A Phase II Multicenter Randomized Open-Label Trial Protocol - Quiz - MDSpire

Accelerated Immuno Chemoradiotherapy Based on FDG-PET/CT for Small Volume in Locally Advanced NSCLC (PACCELIO) – A Phase II Multicenter Randomized Open-Label Trial Protocol

  • By

  • Rami El Shafie

  • Jonas Willmann

  • Eleni Gkika

  • Tanja Schimek-Jasch

  • Matthias Miederer

  • Farastuk Bozorgmehr

  • Frank Griesinger

  • Farkhad Manapov

  • Petros Christopoulos

  • Thomas Hehr

  • Markus Hecht

  • Rebecca Bütof

  • Martin Stuschke

  • Matthias Guckenberger

  • Gerald Schmid-Bindert

  • Jan Meiners

  • Sascha Herzer

  • Sonja Hartmann

  • Joana Lamché

  • Stefan Rieken

  • Ursula Nestle

  • April 17, 2026

  • 0 min

Share

Original Source(s)

Accelerated Immuno Chemoradiotherapy Based on FDG-PET/CT for Small Volume in Locally Advanced NSCLC (PACCELIO) – A Phase II Multicenter Randomized Open-Label Trial Protocol

  • by Rami El Shafie, Jonas Willmann, Eleni Gkika, Tanja Schimek-Jasch, Matthias Miederer, Farastuk Bozorgmehr, Frank Griesinger, Farkhad Manapov, Petros Christopoulos, Thomas Hehr, Markus Hecht, Rebecca Bütof, Martin Stuschke, Matthias Guckenberger, Gerald Schmid-Bindert, Jan Meiners, Sascha Herzer, Sonja Hartmann, Joana Lamché, Stefan Rieken, Ursula Nestle

  • April 17, 2026

Related Content

High-grade astrocytoma with piloid features: a case report of comprehensive management

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer